Related Experiment Video

Updated: Sep 12, 2025

Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs
11:00

Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs

Published on: June 12, 2018

14.0K

CircRNA aptamer targets IGF2BP2 to overcome acquired BETi resistance

Christophe Nicot1

  • 1Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA. cnicot@kumc.edu.

Molecular Cancer
|August 10, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

639
PAR-CliP - A Method to Identify Transcriptome-wide the Binding Sites of RNA Binding Proteins
12:24

PAR-CliP - A Method to Identify Transcriptome-wide the Binding Sites of RNA Binding Proteins

Published on: July 2, 2010

53.6K

Related Experiment Videos

Last Updated: Sep 12, 2025

Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs
11:00

Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs

Published on: June 12, 2018

14.0K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

639
PAR-CliP - A Method to Identify Transcriptome-wide the Binding Sites of RNA Binding Proteins
12:24

PAR-CliP - A Method to Identify Transcriptome-wide the Binding Sites of RNA Binding Proteins

Published on: July 2, 2010

53.6K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Experimental RNAi02:15

Experimental RNAi

6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K

Articles linked to this work by shared authors, journal, and citation graph.

c-Myc: Central regulator of autophagy and senescence in cancer.

Cancer letters·2026

Jab1 regulates HRR mRNA stability to modulate PARP inhibitor sensitivity in triple-negative breast cancer.

Molecular cancer·2025

EMT and cancer stem cells: Drivers of therapy resistance and promising therapeutic targets.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2025

TGF-β-driven EMT in cancer progression and drug resistance.

Cytokine & growth factor reviews·2025

PARP inhibition elicits NK cell-associated immune evasion via potentiating HLA-G expression in tumor.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2025

Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy.

Cytokine & growth factor reviews·2025

Advances in improving cancer immunotherapy with nanotechnology: from smart nanoparticles to synergistic combination strategies.

Molecular cancer·2026

Radiotherapy and tertiary lymphoid structures: balancing immune activation and immune damage in cancer immunotherapy.

Molecular cancer·2026

Spatial proteomics reveals four-stage molecular evolution in cancer immunotherapy-related gastritis.

Molecular cancer·2026

Evidence of endothelial anergy and T-cell exclusion in microsatellite stable colorectal liver metastases revealed through human hemi-liver perfusion and spatial transcriptomics.

Molecular cancer·2026

RNA modifications in cancer: regulators of tumor evolution and therapeutic response.

Molecular cancer·2026

ADSL drives fumarate mediated scrib-rictor complex formation to promote metastasis dissemination in triple-negative breast cancer.

Molecular cancer·2026

IVUS-Guided UNICORN Leaflet Modification During Redo TAVR to Prevent Coronary Obstruction.

JACC. Case reports·2026

Mitral Transcatheter Edge-to-Edge Repair in Younger Adults.

Journal of the American Heart Association·2026

Reframing Person-Centered Fundamental Care in the Age of Artificial Intelligence, Robotics and Posthumanization: A Theory-Informed Narrative Review.

Journal of multidisciplinary healthcare·2026

Advanced 3D echocardiographic assessment of the aortic valve and aortic root complex: a repair-oriented perspective.

European heart journal. Imaging methods and practice·2026

From diagnostic dilemma to successful management: Early prosthetic mitral valve endocarditis complicated by splenic infarction caused by Klebsiella pneumoniae.

Radiology case reports·2026

Thrombin-Responsive Multiarmed Nanovesicles for Targeted Delivery of Tissue Plasminogen Activator and MRI-Monitored Thrombolysis.

Advanced healthcare materials·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us